Seeking Alpha

Delcath Systems (DCTH +5.9%) is trading higher today following its announcement over the weekend...

Delcath Systems (DCTH +5.9%) is trading higher today following its announcement over the weekend that data from a Phase 3 trial of its chemosaturation system showed extended survival rates for patients with melanoma metastases in the liver. The company also says that separate data from a Phase 2 tests of the same system in a different application showed positive results as well.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs